Eosinophilic granulomatosis with polyantiitis: Difference between revisions

From IDWiki
(Created page with "== Background == * Small-vessel ANCA-associated vasculitis * Also known as Churg-Strauss disease == Clinical Manifestations == * Thought to follow separate stages, though there is overlap: ** Prodromal phase, with atopy, allergic rhinitis, asthma, chronic rhinosinusitis ** Eosinophilic phase, with peripheral eosinophilia (greater than 0.5), with a mean eosinophil count of 7.5 ** Vasculitic phase, with the development of end-organ damage f...")
 
 
Line 17: Line 17:
* Eosinophilic gastritis or enteritis, with abdominal pain (605), diarrhea (30%), GI bleed (20%)
* Eosinophilic gastritis or enteritis, with abdominal pain (605), diarrhea (30%), GI bleed (20%)
* Myalgias and arthralgias and even arthritis (40-50%)
* Myalgias and arthralgias and even arthritis (40-50%)
* Lymophadenopathy (30-40%)
* Lymphadenopathy (30-40%)


[[Category:Rheumatology]]
[[Category:Rheumatology]]

Latest revision as of 15:36, 5 September 2024

Background

Clinical Manifestations

  • Thought to follow separate stages, though there is overlap:
    • Prodromal phase, with atopy, allergic rhinitis, asthma, chronic rhinosinusitis
    • Eosinophilic phase, with peripheral eosinophilia (greater than 0.5), with a mean eosinophil count of 7.5
    • Vasculitic phase, with the development of end-organ damage from vasculitis, often with fevers, malaise, and weight loss
  • Asthma (90%), which precedes vasculitis by around 10 years
  • Allergic rhinitis, recurrent sinusitis, nasal polyposis, nasal obstruction, characterized by nasal discharge (90%), congestion (85%), facial pain/pressure (85%)
  • Skin involvement during the vasculitic phase, with tender subcutaneous nodules particularly on the elbows, hands, and legs
  • Peripheral neuropathy (mononeuritis multiplex) (75%)
  • Kidney injury (25%)
  • Eosinophilic gastritis or enteritis, with abdominal pain (605), diarrhea (30%), GI bleed (20%)
  • Myalgias and arthralgias and even arthritis (40-50%)
  • Lymphadenopathy (30-40%)